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Introduction: Members of the Camelidae family are very adaptable mammals,
originating from South America. More recently, they have become popular in Europe
as pets or wool production farm animals. Their dermatological problems refer mainly to
mange, of which sarcoptic mange represent the most clinically relevant form. There is
a wide range of molecules effective against sarcoptic mange, but the treatment is very
challenging due to the lack of efficiency and absorption.
Methods: Two cases from two different animal populations were described. A female
alpaca from Romania with dermatological problems on the ears and two adult llamas,
from Italy, both with intense pruritus. Combined treatment with amitraz and subcutaneous
eprinomectin was administered for the alpaca, and 2% moxidectin was given to
the llamas.
Results: In both cases, the mites were morphologically identified as Sarcoptes scabiei.
For the alpaca, negative scrapings were found only after 8 weeks of combined treatment.
For the llamas, after four doses of subcutaneous moxidectin, no mites were detected in
scrapings and lively hair regrowth of previously alopecic areas was visible.
Conclusion: This paper aimed to present two clinical scenarios of sarcoptic mange
in camelids, successfully treated with a combination of ectocides (topical amitraz and
subcutaneous eprinomectin) and 2% subcutaneous moxidectin, respectively.
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INTRODUCTION
Alpacas and llamas are members of the Camelidae family and are very adaptable mammals,
originating from South America, where they are kept for meat, hides, and high-quality wool. In
the last decades, they have become increasingly popular in Europe as pets or wool production farm
animals (1, 2). Due to the increased interest in South American Camelids, veterinarians should be
aware of their husbandry practices, including their specific diseases. The most common conditions
are related to the digestive tract, metabolic disorders, skin lesions and eye problems (2–4). Several
types of mites have been reported in alpacas; however, sarcoptic mange seems to be the most
severe in regard with the clinical manifestations (2, 5, 6). Lesions due to scabiosis appear first in
the head area, and they can extend to the legs or even the whole body, manifested in the form of
Deak et al. Sarcoptic Treatment in Camelids
alopecia and excoriations (2). The intense pruritus can lead even
to self-trauma and sometimes secondary bacterial infections can
occur (2). Even though there is a wide range of ectoparasitic
molecules effective against sarcoptic mange, in camelids, the
treatment is more challenging as pour-on solutions are not well
absorbed (7) and the systematic formulations are poorly efficient.
Up to now, there are no specific products available for the
treatment of sarcoptic mange in camelids and all the reports
about effective treatments are involving a long period of time (2,
6, 8). Here, we report two clinical scenarios of sarcoptic mange:
a case of an infestation with Sarcoptes mites in an alpaca with
severe ear skin lesions from a zoo in Romania and its progress
after successful treatment with a combination of amitraz and
injectable eprinomectin and a case of infestation with Sarcoptes




A 5-year-old female alpaca (Bonnie) was brought to our attention
by the animal care worker who noticed some dermatological
problems. The alpaca was part of a three-animal group (two
females and one male) from the public zoo in Galaţi, south-
eastern Romania. The animals were housed together in an outside
paddock with free access to an inside shelter. The animal was
donated to the zoo, together with another alpaca by its former
private owner who kept it as a pet. Both donated alpacas were
kept in quarantine for 14 days before introducing them in
the paddock with the other alpaca from the zoo. As part of
the routine parasite control program, all alpacas were given
an annual subcutaneous shot of ivermectin (1 mL/50 kg), with
the last dose was given in September 2019. In August 2020,
the zoo veterinarian performed a clinical examination of the
herd and skin lesions on the ears accompanied by restlessness
were observed in one of the animals. No other clinical signs
were noted, and no other animals were clinically affected. The
patient was restrained and a skin sample containing crusts, scabs
and plucked hair was collected and sent to the Department of
Parasitology and Parasitic Diseases at USAMV Cluj-Napoca. The
skin sample underwent a direct examination under a stereo zoom
microscope. In addition, artificial digestion of the crusts, using
10% KOH was performed. The collected crusts were mixed with
200mL of 10% potassium hydroxide solution and heated until
boiling. The digestion was interrupted after 3min, when the
skin particles were dissolved. The material was transferred to
50mL corning tubes and centrifuged for 2min at 1,000 rpm. The
supernatant was discharged, and the sediment was poured into a
Petri dish. Mites were cleared from the skin crusts and analyzed
under an optical microscope (Olympus BX61). Part of the mites
was mounted on slides with lactophenol and morphologically
identified. Treatment with doramectin (Dectomax, Zoetis, US)
1 mL/50 kg was injected subcutaneously four times at 2-week
intervals. The other two alpacas were also treated even though
they did not present any lesions. Every 2 weeks, all the animals
from the same group were visually inspected in order to follow
the evolution of the disease. Since no improvement was noted,
after 2months, the alpaca with the clinical disease was transferred
to the Department of Parasitology and Parasitic Diseases,
USAMV Cluj-Napoca. A complete physical examination was
performed, followed by hematology and blood biochemistry.
Two cutaneous samples were collected using sterile swabs for
detection of secondary fungal and bacterial associated infections
using specific culture media. A multivitamins and minerals
complex (Selevit, Pasteur Institute, Romania, 5 mL/animal) was
orally administered daily for 2 weeks in order to help the
recovery and acclimatization to the new environment. Local
treatment with salicylic acid (BingoSpa, Poland) (100%) mixed
with glycerol (BingoSpa, Poland) (99.5%) was applied for five
consecutive days for removing the hyperkeratotic crusts. The
ear pinas were washed weekly with chlorhexidine 3% shampoo
(DouxoS3, Ceva Sante Animale, UK) for the whole period
of the treatment, followed by local application of amitraz
(0.5mL diluted in 200mL water, 12.5% Scobatox, Pasteur,
Romania) using a clean sponge. Eprinomectin (Eprecis, Ceva
Sante Animale, UK) 0.6mL (1 mL/100 kg) was administered
subcutaneously weekly for 8 weeks. Every week, the animal
was removed from the shelter for a cleansing protocol and
5 g tetramethrin + 50 g transmix (Neostomosan, Ceva Sante
Animale, UK) (1:200 dilution) was sprayed in the room. Skin
scrapings were collected every week to evaluate the efficacy of
the treatment, until negative for 2 months. After the complete
recovery, the animal was sent back to the zoo.
The animal was legally transported from Galaţi to Cluj-
Napoca, regarding the national legislation. Approval of the
bioethical committee was not necessary since we did not do any
experimental procedures on it. During its stay in Cluj-Napoca,
the animal was housed accordingly.
Case 2
The second episode refers to a couple of adult llamas, a 45 kg
4-year-old female (Pacha) and a 40 kg yearling male (Cuzco),
owned by the managers of a recreational teaching farm in
Caselette, north-western Italy. Like the fore mentioned alpaca,
patients were part of a three-animal group including an adult
female goat, housed in a paddock with free access to an indoor
shelter. Both llamas were purchased from a nearby llama farm on
April 3rd, 2019. According to owners, on arrival both animals
appeared in excellent body condition and no skin lesions nor
pruritus were observed. No quarantine nor any anti-parasitic
treatment were applied before putting llamas in contact with the
single adult goat already inhabiting the paddock. In mid-May,
owners recorded itching in all animals and obvious alopecia and
reddening on the distal hindlimbs of the male llama. Based on
contagiousness and symptoms, a local large animal practitioner
clinically suspected “mange” and applied to all animals a
twofold subcutaneous treatment with 2% ivermectin (Ivomec R©,
Boehringer Ingelheim) at the approximate dose of 200µg/kg b.w.
at 11-days intervals. Since no clinical improvement was observed
in llamas, a third dose of ivermectin treatment was administered
after 8 days, with poor results. This prompted the request for
a second opinion by the Parasitology unit of the Department
of Veterinary Sciences, University of Turin. Patients were first
visited on site on June 25th. Itching was noticeable in all animals
Frontiers in Veterinary Science | www.frontiersin.org 2 September 2021 | Volume 8 | Article 742543
Deak et al. Sarcoptic Treatment in Camelids
FIGURE 1 | Alpaca (case no. 1), ear pinnae. Evolution of skin lesions from severe crusting dermatitis, hyperkeratosis, focal ulceration, alopecia, and scaling (a) to
moderate to severe crusting, hyperkeratosis, scaling, erythema and alopecia (b) to mild to moderate alopecia, erythema and scaling (c) to mild alopecia and
erythema (d).
in the paddock. Both, the llamas, and the goat were physically
restrained, and, besides recording and documenting skin lesions,
deep skin scrapings were obtained from multiple sites at the
margins of affected skin. Collected samples were digested in a
10% KOH solution for 2 h at room temperature, and numerous
Sarcoptes mites of all stages were microscopically observed in
all scrapings from llamas though not from the female goat. A
new therapeutic plan was suggested limited to clinically affected
llamas, including an initial twofold subcutaneous administration
of 2% moxidectin (Cydectin R©, Virbac, Italy) at the approximate
dose of 600µg/kg b.w. at approximately 10-days apart, eventually
followed by similar additional administrations in the event
of persistent mite positive scrapings independently of clinical
improvement. It was established that the treatment plan would
have not been suspended before a second serial negative skin
scraping would have been obtained from both llamas.
Ethics approval was deemed unnecessary.
RESULTS
Case 1
Clinical inspection revealed extreme agitation due to pruritus
and the presence of scaly, crusty lesions on the external ears
accompanied by local alopecia, hyperkeratosis, and thickened
skin (Figure 1a). The direct examination of the collected skin
sample showed no evidence of a parasitic infestation, but mites
were detected after being freed from the galleries by performing
the digestion of the skin crusts. The mites were morphologically
identified as Sarcoptes scabiei (Figure 2). Different stages of
Sarcoptes were detected: eggs, larvae, adult females, and
males. No other mites were detected. Blood biochemistry and
hematology showed no abnormal values. Secondary infections
with bacteria or fungi were not detected.
Two weeks after the first treatment, the lesions failed to
improve. However, crusts were almost completely removed after
10 days of topical application of 3% chlorhexidine shampoo and
the salicylic acid. After 1 month from the combined antiparasitic
treatment in the new location, alive and dead mites were still
FIGURE 2 | Morphological features of Sarcoptes scabiei mites.
present in the skin scrapings. After another two weeks, all the
detected mites were dead and by the end of the treatment
(8 weeks), no mites were detected. The monthly evolution of
the skin lesions is presented in Figure 1. None of the people
involved in handling the alpaca, nor the zookeepers manifested
any pruritus or other dermatological conditions. The animal
was followed by phone, by questioning the zoo owner. After 5
months, no relapse was noticed.
Case 2
At first consultation (Day 0), severe itching was obvious on
both llamas though skin lesions were far more extensive in
Cuzco, including: severe, diffuse scaling, particularly noticeable
after hair clipping; skin reddening on the belly, axillae and, to
a lower extent, on forelegs and hind limbs; hair thinning to
alopecia on the belly, axillae, forelegs, distal fore and hind limbs,
posterior and internal aspects of the proximal hind limbs; skin
wrinkling on the last mentioned areas on the hind limbs; soft
and relatively thin (≤ 2mm) exudative crusts on medial cantus
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FIGURE 3 | Llamas (case no. 2), skin lesions. (a) Hind limb (after clipping): alopecia, moderate to severe erythema, severe scaling and focal crusts; (b) Hind limbs,
perianal, peri vulvar region and ventral aspect of the tail: alopecia, mild erythema and scaling and mild, focal lichenification; (c) Ventral abdomen and axillae: extensive
alopecia, moderate to severe erythema and focal hyperpigmentation.
of the eye, the ventral aspect of the tail, the perianal zone and the
perineum (Figure 3). Skin lesions were more localized in Pacha,
in which reddening and hypotrichosis to alopecia, on the axillae,
forelimbs, external pinnae and internal aspect of the thighs, and
thin, soft (≤1mm) crusts in the perianal zone were recorded.
Trivial dermatological signs were observed in the cohabiting
goat, including mild pruritus, a dull coat and small scattered
alopecic areas on the neck and shoulders, possibly because of
scratching. At second consultation (Day 10 post-treatment–PT),
after the treatment, signs had disappeared in the goat though
not in the llamas, in which severe itching was persistently
noticed by owners in the time interval from the first moxidectin
administration. On handling, the only clinical improvement was
the attenuation of skin reddening on Cuzco’s belly and axillae and
the initial drying of the localized crusty lesions in both llamas.
Skin scrapings remained positive in both patients, whereas the
recovered goat was not sampled. Mites of all stages were observed
in Cuzco, though only eggshells, larvae and a few nymphs were
present in Pacha. At third consultation (Day 19 PT), after the
second dose of moxidectin, mild itching was observed only
in Cuzco. In this patient, a general attenuation of scaling and
skin reddening was present, together with the disappearance of
crusty lesions in the perianal and perineal zone and their further
drying in the periocular zone. In Pacha, clinical improvement was
evident, including the disappearance of skin reddening, clearance
of perianal crusty lesions and the observation of initial hair
regrowth on the previously alopecic area. At skin scraping, no
mites were detected in Pacha whereas larvae, eggshells and a
few larvated eggs and nymphs were still observed in Cuzco. A
third dose of moxidectin was administered to both llamas and
at fourth consultation (Day 30 PT) no itching was recorded on
any animals nor any skin alterations were detectable on Pacha
and the goat. In Cuzco, crusts on the periocular zone had cleared
and the only persisting alterations were attenuated skin wrinkling
on the posterior aspect of the proximal hind limbs and the
incomplete hair regrowth in previously alopecic zones. No mites
were present in the skin scrapings of both llamas. A fourth dose
of moxidectin was administered to them followed by the fifth and
final consultation (Day 40 PT), with no clinical signs detected
on any of the animals. A lively hair regrowth of previously
alopecic areas was present in Cuzco. Skin scrapings blindly
obtained from previously affected areas of both llamas yielded
negative results. According to protocol, no further treatments
were applied. Periodic phone contacts with the llama owners in
the 12 months that followed the closure of the case witnessed no
relapse and a healthy state in all animals.
DISCUSSION
Sarcoptic mange in llamas and alpacas represents a severe,
sometimes lethal, dermatological condition (9–11). In various
wildlife, S. scabiei is responsible for high morbidity and mortality
(12). Treatment of scabies in camelids is challenging, with no
specific labeled products available in Europe. Several molecules
were used in the treatment of sarcoptic mange in alpacas,
with low to moderate efficacy (2, 10). In one study (10), three
alpacas had to be euthanized as one of the same groups died
and the others did not respond to treatment with three doses
of doramectin, nor with three doses of ivermectin, amitraz or
diazinon (10). Repeated treatment with subcutaneous 0.2 mg/kg
ivermectin was reported as effective in treating sarcoptic mange
in alpacas, but after long-term administration of at least eight
doses (11). However, ivermectin was not suitable in none of our
present cases for treating sarcoptic mange. Topical treatment
with amitraz was successfully used in three S. scabiei-infected
alpacas from UK with travel history, after the diseases failed
to respond to topical eprinomectin administered in several
doses (13). In Belgium, a severe case of sarcoptic mange in an
alpaca was finally treated after 3 years of struggle, with 10%
moxidectin (1 mg/kg) long-acting subcutaneous injection (14).
A similar situation was presented in our case 2, from Italy, where
successful treatment was achieved by using long-term high dose
moxidectin. However, in other studies, topical treatment with
doramectin, eprinomectin or moxidectin had limited efficacy in
treating sarcoptic mange in alpacas (7, 15–17). This may be due
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to hyperkeratosis, a typical lesion developed in alpaca affected
by sarcoptic mange which can influence the penetration and
absorption of topical molecules (6). Another cause suggested for
the poor efficacy of topical acaricides is the lack of lanolin (the
woold grease), which can limit their efficacy (6, 18). Considering
these, in the first case study we used a combined treatment
with topical amitraz and subcutaneous eprinomectin, only after
the thick crusts were removed with keratolytics in order to
facilitate the absorption of the topical acaricide. However, we
used this protocol on only one patient, and it could be very
time consuming and costly in the case of bigger herds. In
another study, the successful treatment of a mixed infestation
with sarcoptic and chorioptic mange mites in one alpaca
was achieved using a combination of topical amitraz and 0.5
mg/kg subcutaneous ivermectin for nine consecutive weeks (6).
Combined treatments seem to be more efficient, especially when
associated with local shampooing with chlorhexidine, vitamins,
and environmental treatment (2, 6). Pour-on eprinomectin (0.5
mg/kg) was used in the treatment of chorioptic mange in
alpacas with (15) or without (16) success. Only in one of all
these studies, the animals were followed for a longer period
(that is about one year) in order to be sure that the disease
did not recur (13). Unfortunately, all the effective treatments
reported until now are time consuming and take a long period
of time. The elaboration of specific products, with a faster period
of treatment would greatly improve the present situation. In
both cases reported in this study, the source of the infection
is unknown. In the second case, it is unlikely that infection
originated from the single domestic goat with which llamas were
put into cohabitation, since authors’ clinical experience and a
previous regional serological survey suggest that is extremely
rare that exposure to Sarcoptes infection occurs in domestic
goats in Northern Italy (19). Similarly, as in other models (20,
21), molecular epidemiological studies are advisable to clarify
if sarcoptic scabies episodes in South American camelids raised
in Europe are traceable back to spill over from other domestic
reservoirs or derive from the circulation of imported Sarcoptes
strains adapted to these specific hosts.
To the best of our knowledge, we present in this paper two
new effective therapeutic protocols for the treatment of sarcoptic
mange in European camelids.
CONCLUSION
We present two clinical scenarios of sarcoptic mange, one in
an alpaca from a zoo in Romania, and one in two llamas
from a farm in Italy, successfully treated with a combination
of 3% chlorhexidine, keratolytics, followed by ectocides (topical
amitraz and subcutaneous eprinomectin) and 2% subcutaneous
moxidectin, respectively.
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